To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NRD1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
387 representative clones for gene NRD1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB062589 testis .a 1 to 340 2 to 343   tiling clone, capped   342/342
(100 %)
2 diff
(99.5 %id)
NM_002525.2   .a 27 to 4048 1 to 4022 exact RefSeq, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 4022/4022
(100 %)
0 diff
(100 %id)
DA756064   .a 28 to 610 2 to 584   tiling clone, capped   583/583
(100 %)
1 diff
(99.9 %id)
X93207 testis .a 214 to 4032 1 to 3819 E23D L24V Q595L V821A T1168S tiling clone, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 3819/3819
(100 %)
13 diff
(99.7 %id)
DA795147 brain .a 728 to 1286 2 to 555   capped   554/560
(98 %)
10 diff
(98.3 %id)
BP229241 brain .a 783 to 1363 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DB258771 uterus .a 935 to 1490 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CF553012 Pooled muscle (cardiac and skeletal) .a 1169 to 1964 26 to 832       807/922
(87 %)
15 diff
(98.4 %id)
NM_001101662.1   .b 1 to 3818 1 to 3818 exact RefSeq, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 3818/3818
(100 %)
0 diff
(100 %id)
AL039734 testis .b 18 to 396 1 to 379   tiling clone,   379/379
(100 %)
1 diff
(99.8 %id)
DA245717 brain .b 128 to 716 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DB071958 testis .b 134 to 677 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB089704 testis .b 134 to 702 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA222562 brain .b 143 to 715 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA304879 hippocampus .b 143 to 718 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA722650   .b 163 to 731 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA119285 cerebellum .b 167 to 627 2 to 462   capped   461/461
(100 %)
0 diff
(100 %id)
BM479395 eye, retinoblastoma .b 167 to 950 1 to 786       786/1058
(74 %)
12 diff
(98.9 %id)
DB224221 trachea .b 173 to 761 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA740181   .b 179 to 690 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
DB088509 testis .b 179 to 716 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB454998 testis .b 187 to 682 1 to 496       496/496
(100 %)
0 diff
(100 %id)
DB457343 testis .b 187 to 662 1 to 476       476/476
(100 %)
0 diff
(100 %id)
DA120731 cerebellum .b 188 to 745 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB100267 testis .b 188 to 761 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
X93209 testis .b 188 to 3802 1 to 3615 E23D L24V Q527L V753A T1100S AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 3615/3615
(100 %)
13 diff
(99.7 %id)
AK312318 cerebellum .b 189 to 3778 1 to 3590 exact tiling clone,   3590/3590
(100 %)
0 diff
(100 %id)
DA317652 hippocampus .b 189 to 730 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA406969 thalamus .b 189 to 722 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA726871   .b 189 to 747 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA757657   .b 189 to 742 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB068708 testis .b 189 to 740 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB094574 testis .b 189 to 739 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB096788 testis .b 189 to 774 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DB096795 testis .b 189 to 766 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB097550 testis .b 189 to 726 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB139349 thymus .b 189 to 711 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
DA104481 cerebellum .b 190 to 729 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA105068 cerebellum .b 190 to 747 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA120833 cerebellum .b 190 to 726 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA310633 hippocampus .b 190 to 784 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DB076395 testis .b 194 to 706 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
DA233212 brain .b 196 to 791 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA785513 brain .b 203 to 780 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA726687   .b 204 to 754 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA462153 tongue, tumor tissue .b 205 to 608 2 to 405   capped   404/404
(100 %)
0 diff
(100 %id)
DB219218 trachea .b 206 to 742 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA008060   .b 207 to 753 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA754164   .b 207 to 771 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB156735 thymus .b 207 to 778 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA186357 amygdala .b 208 to 750 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB092716 testis .b 208 to 769 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA481324   .b 210 to 749 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA741398   .b 211 to 757 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA034374   .b 212 to 740 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA070417 cerebellum .b 212 to 775 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA100195 cerebellum .b 212 to 762 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA112869 cerebellum .b 212 to 746 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA114464 cerebellum .b 212 to 772 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA189098 amygdala .b 212 to 763 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA193275 amygdala .b 212 to 807 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA318670 hippocampus .b 212 to 774 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA320962 hippocampus .b 212 to 771 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA330971 hippocampus .b 212 to 772 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA402513 thalamus .b 212 to 754 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA477503   .b 212 to 768 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AU133117   .b 212 to 969 2 to 758   capped   757/757
(100 %)
3 diff
(99.7 %id)
DA801269 brain .b 212 to 765 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA810325 brain .b 212 to 763 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA950989 Spleen .b 212 to 777 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB063080 testis .b 212 to 755 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB066044 testis .b 212 to 755 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB069718 testis .b 212 to 746 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DB099594 testis .b 212 to 777 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB158340 thymus .b 212 to 815 2 to 605   capped   604/604
(100 %)
0 diff
(100 %id)
DB178585 kidney, tumor tissue .b 212 to 767 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB217621 trachea .b 212 to 740 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DB221238 trachea .b 212 to 770 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB278068 uterus .b 212 to 743 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DB284447 uterus .b 212 to 747 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA034320   .b 215 to 690 2 to 477   capped   476/476
(100 %)
0 diff
(100 %id)
BP286578 lung .b 215 to 798 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA478159   .b 216 to 778 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA643478   .b 216 to 706 2 to 492   capped   491/491
(100 %)
0 diff
(100 %id)
DA643829   .b 216 to 568 2 to 354   capped   353/353
(100 %)
0 diff
(100 %id)
DA655302   .b 216 to 776 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA756214   .b 216 to 707 2 to 493   capped   492/492
(100 %)
0 diff
(100 %id)
DA756445   .b 216 to 768 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB218018 trachea .b 216 to 772 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB228285 trachea .b 216 to 754 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB074987 testis .b 218 to 763 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DB289007 uterus .b 218 to 768 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA478037   .b 220 to 777 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BQ226210 melanotic melanoma, skin .b 223 to 1085 1 to 866       866/866
(100 %)
3 diff
(99.7 %id)
BC008775 Placenta, choriocarcinoma .b 224 to 3802 1 to 3576 E154D D157E E158D D159S S160G ... available from MGC, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 3576/3576
(100 %)
3 diff
(100.0 %id)
U64898 heart .b 232 to 3802 7 to 3575 E154D D157E E158D D159S S160G ... AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 3569/3575
(99 %)
14 diff
(99.7 %id)
DB019954 testis .b 236 to 770 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
CN267312 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 241 to 582 1 to 342       342/342
(100 %)
0 diff
(100 %id)
CN267295 embryonic stem cells, cell lines H1, H7, andH9 .b 245 to 685 1 to 441       441/441
(100 %)
0 diff
(100 %id)
DB078352 testis .b 264 to 808 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
AY049784   .b 283 to 3235 1 to 2951       2951/2951
(100 %)
3 diff
(99.9 %id)
BG990122 head_neck .b 511 to 663 191 to 40       152/191
(79 %)
0 diff
(100 %id)
AK299271   .b 551 to 3802 1 to 3249       3249/3249
(100 %)
3 diff
(100.0 %id)
DR157819 human embryonic stem cells differentiated toan early endodermal cell type .b 573 to 1084 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BM476657 lymph, lymphoma, cell line .b 661 to 1539 1 to 883       883/993
(88 %)
8 diff
(99.2 %id)
BM787406 stomach .b 716 to 1272 1 to 557       557/557
(100 %)
0 diff
(100 %id)
CN267302 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 748 to 1404 1 to 657       657/657
(100 %)
0 diff
(100 %id)
AL135202 melanoma (MeWo cell line) .b 769 to 1277 1 to 509       509/509
(100 %)
0 diff
(100 %id)
GD144426   .b 866 to 929 1 to 64   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 64/73
(87 %)
2 diff
(97.3 %id)
BQ716922 sympathetic trunk .b 935 to 1818 1 to 896       896/925
(96 %)
25 diff
(97.3 %id)
BM474841 duodenal adenocarcinoma, cell line, small intestine .b 978 to 1881 1 to 911       911/1001
(91 %)
14 diff
(98.7 %id)
FN094320 breast carcinoma .b 1081 to 1142 61 to 1     Submitted on the opposite strand 61/62
(98 %)
1 diff
(98.4 %id)
BU184857 melanotic melanoma, cell line, skin .b 1163 to 1823 245 to 910       666/910
(73 %)
17 diff
(98.2 %id)
BU179413 melanotic melanoma, cell line, skin .b 1163 to 1803 245 to 894       650/896
(72 %)
26 diff
(97.1 %id)
BU166431 melanotic melanoma, cell line, skin .b 1163 to 1794 245 to 883       639/899
(71 %)
20 diff
(97.8 %id)
BU166671 melanotic melanoma, cell line, skin .b 1163 to 1761 245 to 851       607/906
(66 %)
15 diff
(98.4 %id)
BU168915 melanotic melanoma, cell line, skin .b 1163 to 1854 245 to 939       695/939
(74 %)
27 diff
(97.2 %id)
BQ677092 melanotic melanoma, cell line, skin .b 1163 to 1824 245 to 917       673/974
(69 %)
28 diff
(97.2 %id)
DB490712 hypothalamus .b 1182 to 1607 1 to 426       426/426
(100 %)
0 diff
(100 %id)
DB501655 hypothalamus .b 1182 to 1655 1 to 474       474/474
(100 %)
0 diff
(100 %id)
DB200205 trachea .b 1182 to 1732 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB012173 esophageal, tumor tissue .b 1351 to 1860 2 to 511   capped   510/510
(100 %)
0 diff
(100 %id)
DB043278 testis .b 1351 to 1925 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA543816   .b 1371 to 1936 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA024582   .b 1401 to 1973 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA051103   .b 1404 to 1996 2 to 594   capped   593/602
(98 %)
0 diff
(100 %id)
DA481523   .b 1462 to 2003 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA815790   .b 1480 to 2040 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BM743120 stomach .b 1508 to 2103 1 to 596       596/596
(100 %)
0 diff
(100 %id)
DB023522 testis .b 1578 to 2130 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
CB153563 brain .b 1604 to 2166 1 to 563       563/563
(100 %)
0 diff
(100 %id)
DA198251 brain .b 1606 to 2109 2 to 501   capped   504/500
(100 %)
0 diff
(100 %id)
DA750821   .b 1606 to 2172 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA951733 Spleen .b 1606 to 2168 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
CV573459 cornea, eye .b 1672 to 2275 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BM563314 astrocytoma grade IV, cell line, brain .b 1690 to 2634 1 to 956       956/1024
(93 %)
21 diff
(98.0 %id)
DA697548   .b 1719 to 2283 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BQ943962 carcinoma, cell line, Prostate .b 1723 to 2635 1 to 911       911/913
(99 %)
10 diff
(99.0 %id)
BM706214.
matches multiple genes
eye, lens .b 1755 to 2387 1 to 633     also hits gene CRYAA 633/633
(100 %)
0 diff
(100 %id)
BQ922661 sciatic nerve .b 1766 to 2642 1 to 881       881/928
(94 %)
15 diff
(98.4 %id)
BP218427 caudate nucleus .b 1810 to 2391 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CX868805 embryonic stem .b 1864 to 2717 1 to 854       854/854
(100 %)
0 diff
(100 %id)
DB032248 testis .b 1867 to 2372 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
BG388295 embryonal carcinoma, cell line, testis .b 1868 to 2517 1 to 651       651/943
(69 %)
2 diff
(99.8 %id)
DA067032 cerebellum .b 1874 to 2457 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA482453   .b 1882 to 2451 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BP252945 Kidney .b 1908 to 2489 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CX868201 embryonic stem .b 1932 to 2610 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
CX868508 embryonic stem .b 1932 to 2538 1 to 607       607/607
(100 %)
0 diff
(100 %id)
CX870426 embryonic stem .b 1938 to 2777 1 to 840       840/840
(100 %)
0 diff
(100 %id)
BJ996458 hepatoblastoma .b 1947 to 2445 1 to 499       499/499
(100 %)
0 diff
(100 %id)
CN267306 embryonic stem cells, DMSO-treated H9 cellline .b 1979 to 2458 1 to 480       480/480
(100 %)
0 diff
(100 %id)
CN267296 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2063 to 2794 1 to 731       731/731
(100 %)
2 diff
(99.8 %id)
AA485997   .b 2112 to 2566 1 to 455       455/455
(100 %)
0 diff
(100 %id)
DA362857 subthalamic nucleus .b 2142 to 2697 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
F05392 brain, total brain .b 2333 to 2541 1 to 209       209/209
(100 %)
0 diff
(100 %id)
F07243 brain, total brain .b 2333 to 2691 1 to 359       359/359
(100 %)
0 diff
(100 %id)
FN050892 breast carcinoma .b 2447 to 2539 93 to 1     Submitted on the opposite strand 93/94
(98 %)
2 diff
(97.9 %id)
CX786661 human embryonic stem cells .b 2485 to 3258 8 to 781       774/781
(99 %)
0 diff
(100 %id)
BM472426 embryonal carcinoma, cell line, testis .b 2490 to 3378 1 to 890       890/968
(91 %)
7 diff
(99.3 %id)
BF725662 eye, Iris .b 2549 to 3068 1 to 520       520/520
(100 %)
0 diff
(100 %id)
BQ682474 melanotic melanoma, cell line, skin .b 2596 to 3490 1 to 895       895/903
(99 %)
14 diff
(98.5 %id)
BQ683003 melanotic melanoma, cell line, skin .b 2596 to 3452 1 to 864       864/921
(93 %)
14 diff
(98.5 %id)
BQ684574 melanotic melanoma, cell line, skin .b 2596 to 3490 1 to 897       897/940
(95 %)
16 diff
(98.3 %id)
BQ681427 melanotic melanoma, cell line, skin .b 2596 to 3511 1 to 919       919/920
(99 %)
9 diff
(99.1 %id)
FN106015 breast carcinoma .b 2636 to 2695 59 to 1     Submitted on the opposite strand 59/64
(92 %)
1 diff
(98.5 %id)
BG259826 bladder, transitional cell papilloma, cell line .b 2647 to 3413 1 to 769       769/857
(89 %)
7 diff
(99.2 %id)
DN912720   .b 2669 to 3071 403 to 1       403/403
(100 %)
3 diff
(99.3 %id)
BQ430826 embryonal carcinoma, cell line, testis .b 2715 to 3550 1 to 842       842/854
(98 %)
9 diff
(99.0 %id)
BU189636 melanotic melanoma, skin .b 2823 to 3685 1 to 872       872/873
(99 %)
15 diff
(98.3 %id)
CN267308 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2835 to 3424 1 to 590       590/590
(100 %)
0 diff
(100 %id)
DA955114 Spleen .b 2845 to 3396 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BG696558 skin .b 2887 to 3756 1 to 873       873/877
(99 %)
16 diff
(98.2 %id)
TI_149315563   .b 2924 to 3818 971 to 86   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 888/988
(89 %)
13 diff
(98.7 %id)
TI_154115707   .b 2958 to 3818 957 to 107   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 851/936
(90 %)
14 diff
(98.6 %id)
BG203653   .b 2959 to 3780 834 to 14     Submitted on the opposite strand 821/840
(97 %)
20 diff
(97.7 %id)
BG209940   .b 2959 to 3791 836 to 6     Submitted on the opposite strand 831/878
(94 %)
36 diff
(95.9 %id)
BQ957413 carcinoma, cell line, Prostate .b 2959 to 3802 886 to 34   AAA Submitted on the opposite strand 853/929
(91 %)
28 diff
(97.0 %id)
CB137386 Liver .b 2959 to 3469 1 to 511       511/511
(100 %)
0 diff
(100 %id)
BU541843 carcinoma, cell line, Prostate .b 2960 to 3802 882 to 34   AAA Submitted on the opposite strand 849/883
(96 %)
9 diff
(99.0 %id)
TI_149306378   .b 2961 to 3818 935 to 89   tiling clone, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 847/960
(88 %)
12 diff
(98.8 %id)
BU542063 carcinoma, cell line, Prostate .b 2965 to 3802 876 to 33   AAA Submitted on the opposite strand 844/852
(99 %)
12 diff
(98.6 %id)
TI_149303338   .b 2970 to 3791 879 to 65   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 815/955
(85 %)
9 diff
(99.1 %id)
AI609283 normal gingiva (cell line from primarykeratinocytes) .b 2976 to 3806 827 to 1       827/827
(100 %)
12 diff
(98.6 %id)
CA394670 eye, RPE/choroid .b 2983 to 3467 1 to 485       485/485
(100 %)
0 diff
(100 %id)
BU541544 carcinoma, cell line, Prostate .b 2987 to 3802 854 to 34   AAA Submitted on the opposite strand 821/883
(92 %)
10 diff
(98.9 %id)
TI_149315139   .b 2988 to 3802 870 to 77   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 794/981
(80 %)
20 diff
(98.0 %id)
CB851037 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 3021 to 3791 787 to 19   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 769/769
(100 %)
2 diff
(99.8 %id)
CA307385 Alveolar Macrophage, lung .b 3055 to 3791 755 to 19   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 737/737
(100 %)
1 diff
(99.9 %id)
CX782631 human embryonic stem cells .b 3078 to 3791 1 to 714   fully sequenced, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 714/714
(100 %)
0 diff
(100 %id)
BG194437   .b 3090 to 3789 711 to 9     Submitted on the opposite strand 663/901
(73 %)
29 diff
(96.8 %id)
BU686425 lung, Primary Lung Epithelial Cells .b 3091 to 3818 746 to 19   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 728/728
(100 %)
0 diff
(100 %id)
CD370057 Alveolar Macrophage, lung .b 3131 to 3802 690 to 19   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 672/672
(100 %)
0 diff
(100 %id)
CD675564 eye, lens .b 3136 to 3766 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BF084624 colon .b 3145 to 3296 152 to 1       152/152
(100 %)
0 diff
(100 %id)
BM726925 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3147 to 3798 1 to 652   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 652/656
(99 %)
2 diff
(99.7 %id)
CX782557 human embryonic stem cells .b 3168 to 3791 649 to 26   fully sequenced, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 624/624
(100 %)
2 diff
(99.7 %id)
CA432199 cell lines, Enchondroma .b 3183 to 3791 627 to 19   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 609/609
(100 %)
0 diff
(100 %id)
AV721688 hypothalamus .b 3197 to 3804 1 to 609       609/635
(95 %)
2 diff
(99.7 %id)
BE278891 choriocarcinoma, placenta .b 3198 to 3818 642 to 24   AAA Submitted on the opposite strand 619/675
(91 %)
25 diff
(96.3 %id)
BP421860 small intestine .b 3236 to 3755 1 to 520     Submitted on the opposite strand 520/520
(100 %)
0 diff
(100 %id)
AI925624 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3239 to 3802 564 to 1       564/564
(100 %)
0 diff
(100 %id)
AJ706897 heart .b 3242 to 3653 1 to 412       412/412
(100 %)
0 diff
(100 %id)
AA011246 heart .b 3255 to 3521 1 to 267   fully sequenced,   267/267
(100 %)
0 diff
(100 %id)
BE855723 brain, glioblastoma (pooled) .b 3257 to 3802 546 to 1       546/546
(100 %)
0 diff
(100 %id)
BG389334 embryonal carcinoma, cell line, testis .b 3257 to 3791 1 to 535   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 535/535
(100 %)
0 diff
(100 %id)
CA422553 cell lines, Chondrosarcoma .b 3276 to 3818 561 to 19   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 543/543
(100 %)
0 diff
(100 %id)
BQ029505 lung, Metastatic Chondrosarcoma .b 3289 to 3791 521 to 19   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 503/503
(100 %)
0 diff
(100 %id)
W26231 eye, retina .b 3289 to 3784 513 to 16       498/548
(90 %)
5 diff
(99.1 %id)
DB576009 hypothalamus .b 3300 to 3791 1 to 492     Submitted on the opposite strand 492/492
(100 %)
0 diff
(100 %id)
AA846301 parathyroid gland, parathyroid tumor .b 3302 to 3802 516 to 16   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 501/501
(100 %)
0 diff
(100 %id)
CD108777 brain, Pituitary .b 3314 to 3791 1 to 478       478/479
(99 %)
1 diff
(99.8 %id)
DB522806 testis .b 3349 to 3802 1 to 454     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
BI018574 marrow .b 3364 to 3553 190 to 1       190/190
(100 %)
0 diff
(100 %id)
FN073601 breast carcinoma .b 3371 to 3461 93 to 1     Submitted on the opposite strand 93/106
(87 %)
2 diff
(98.2 %id)
FN138679 breast carcinoma .b 3380 to 3479 98 to 1     Submitted on the opposite strand 98/98
(100 %)
2 diff
(98.0 %id)
AA694089 liver and spleen .b 3391 to 3803 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AU154505   .b 3406 to 3802 397 to 1       397/400
(99 %)
0 diff
(100 %id)
AW069063 bone marrow stroma .b 3421 to 3802 407 to 26   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 382/382
(100 %)
0 diff
(100 %id)
BF904384 marrow .b 3446 to 3783 346 to 2     Submitted on the opposite strand 345/346
(99 %)
0 diff
(100 %id)
AW015896   .b 3455 to 3818 381 to 18   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 364/364
(100 %)
0 diff
(100 %id)
AA010636 heart .b 3460 to 3804 347 to 3   fully sequenced,   345/347
(99 %)
1 diff
(99.8 %id)
F34896 pectoral muscle (after mastectomy) .b 3477 to 3780 1 to 304       304/304
(100 %)
0 diff
(100 %id)
AW817631 stomach .b 3496 to 3770 1 to 275       275/275
(100 %)
0 diff
(100 %id)
AI805897 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3500 to 3793 294 to 1       294/294
(100 %)
0 diff
(100 %id)
FN091352 breast carcinoma .b 3502 to 3604 100 to 1     Submitted on the opposite strand 100/100
(100 %)
3 diff
(97.0 %id)
T34120 blood, white blood cells .b 3514 to 3797 284 to 1     Submitted on the opposite strand 284/284
(100 %)
1 diff
(99.7 %id)
D51105   .b 3522 to 3796 275 to 1       275/275
(100 %)
0 diff
(100 %id)
Z40352 brain, total brain .b 3527 to 3791 265 to 1       265/265
(100 %)
0 diff
(100 %id)
BF904132 marrow .b 3536 to 3784 250 to 3     Submitted on the opposite strand 248/250
(99 %)
1 diff
(99.6 %id)
FN119882 breast carcinoma .b 3546 to 3623 81 to 1     Submitted on the opposite strand 81/82
(98 %)
4 diff
(95.2 %id)
F01648 brain, total brain .b 3567 to 3791 225 to 1       225/225
(100 %)
0 diff
(100 %id)
DB084774 testis .c 1 to 571 2 to 569   tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
DB096330 testis .c 18 to 561 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DB100586 testis .c 18 to 618 2 to 599   capped   598/598
(100 %)
1 diff
(99.9 %id)
AY360265   .c 22 to 3401 1 to 3377 E22D D25E E26D D27S S28G ... tiling clone, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 3377/3377
(100 %)
2 diff
(100.0 %id)
AW341698 pooled .c 3114 to 3763 642 to 1   tiling clone,   642/642
(100 %)
11 diff
(98.3 %id)
AA769452 germinal center B cell .c 3210 to 3763 555 to 10       546/555
(98 %)
0 diff
(100 %id)
EL953716 eyeball .c 3394 to 3975 37 to 616   tiling clone,   580/616
(94 %)
6 diff
(99.1 %id)
BP396013 pancreatic islet .c 3394 to 3723 333 to 1       333/336
(99 %)
4 diff
(98.9 %id)
AJ709224 heart .c 3488 to 4019 1 to 532   tiling clone,   532/532
(100 %)
0 diff
(100 %id)
AK055516   .d 1 to 3148 2 to 3146 K105N tiling clone, available from FLJ,   3146/3146
(100 %)
4 diff
(99.9 %id)
DA542850   .d 1 to 556 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DB318159   .d 2615 to 3148 534 to 1       534/534
(100 %)
0 diff
(100 %id)
AK302616 testis .e 1 to 2557 1 to 2557 V226A tiling clone,   2557/2557
(100 %)
2 diff
(100.0 %id)
DA272208 caudate nucleus .f 1 to 549 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA281437 corpus callosum .f 1 to 549 2 to 550   tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
DB062866 testis .f 542 to 1081 2 to 538   tiling clone, capped   537/537
(100 %)
1 diff
(99.9 %id)
AK311631 testis .f 708 to 2012 1 to 1302 E22D D25E E26D D27S S28G ... tiling clone,   1302/1302
(100 %)
4 diff
(99.7 %id)
DB093579 testis .f 709 to 1255 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
DB095771 testis .f 710 to 1273 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
BF979347 testis .g 1 to 573 1 to 571   tiling clone, fully sequenced,   571/571
(100 %)
9 diff
(98.5 %id)
DB448265 testis .g 32 to 452 1 to 421   tiling clone,   421/421
(100 %)
0 diff
(100 %id)
DB449977 testis .g 32 to 490 1 to 462       462/462
(100 %)
13 diff
(97.2 %id)
BF979897 testis .g 536 to 1352 824 to 6   tiling clone, fully sequenced,   819/824
(99 %)
7 diff
(99.2 %id)
BM927561 lymph, lymphoma, cell line .h 1 to 994 1 to 1001   tiling clone,   1000/1040
(96 %)
20 diff
(98.1 %id)
TI_57201015   .h 235 to 987 84 to 837       754/956
(78 %)
19 diff
(98.1 %id)
BI824507 pooled brain, lung, testis .h 238 to 987 1 to 751       751/870
(86 %)
15 diff
(98.3 %id)
BE537791 cervix .h 282 to 994 1 to 717       715/871
(82 %)
23 diff
(97.4 %id)
BG186656   .h 336 to 990 1 to 651       651/768
(84 %)
10 diff
(98.7 %id)
BG213092   .h 336 to 990 1 to 654       654/769
(85 %)
21 diff
(97.3 %id)
BG169023 hypernephroma, cell line, Kidney .h 382 to 991 1 to 624       569/827
(68 %)
13 diff
(98.5 %id)
AW806450 uterus .h 784 to 990 262 to 56       207/262
(79 %)
0 diff
(100 %id)
AI348432 carcinoid, lung .h 790 to 1216 427 to 1   tiling clone,   427/428
(99 %)
0 diff
(100 %id)
AI298890 carcinoid, lung .h 797 to 1216 420 to 1       420/420
(100 %)
7 diff
(98.4 %id)
CD722367 eye, lacrimal gland .i 1 to 575 1 to 575   tiling clone,   575/575
(100 %)
0 diff
(100 %id)
AA001779 liver and spleen .i 466 to 639 1 to 174   tiling clone,   174/174
(100 %)
4 diff
(97.8 %id)
AA001780 liver and spleen .i 976 to 1367 403 to 4   tiling clone,   400/421
(95 %)
9 diff
(97.9 %id)
DB137020 thymus .j 1 to 506 2 to 508   tiling clone, capped   507/507
(100 %)
1 diff
(99.9 %id)
BP383030 ilea mucosa .j 20 to 784 1 to 766   tiling clone,   766/964
(79 %)
11 diff
(98.9 %id)
DA839695 placenta .k 1 to 561 2 to 562   tiling clone, capped   561/561
(100 %)
2 diff
(99.7 %id)
BX348314 Placenta Cot 25-normalized .k 338 to 1258 1 to 932   tiling clone,   932/993
(93 %)
25 diff
(97.5 %id)
BX348313 Placenta Cot 25-normalized .k 388 to 1258 1 to 868       868/868
(100 %)
12 diff
(98.7 %id)
BE971211 muscle (skeletal) .k 569 to 1270 1 to 718       718/898
(79 %)
52 diff
(94.3 %id)
BU664174 blood .k 961 to 1454 4 to 498       495/498
(99 %)
7 diff
(98.6 %id)
BM709476 eye, optic nerve .k 1002 to 1502 1 to 501   tiling clone, fully sequenced,   501/501
(100 %)
0 diff
(100 %id)
R53695 placenta .k 1209 to 1545 1 to 341       341/341
(100 %)
6 diff
(98.3 %id)
T88838 liver and spleen .k 1232 to 1595 1 to 375       375/375
(100 %)
20 diff
(94.7 %id)
DA864513 placenta .k 1303 to 1886 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
BU733445 eye, optic nerve .k 1472 to 2093 621 to 1   tiling clone, fully sequenced,   621/621
(100 %)
0 diff
(100 %id)
DB154963 thymus .k 1589 to 2147 2 to 554   tiling clone, capped   553/553
(100 %)
5 diff
(99.1 %id)
BG230475 moderate to poorly differentiated invasivecarcinoma, tongue .k 1606 to 2070 1 to 465       465/465
(100 %)
5 diff
(99.0 %id)
AW630675 2 pooled high-grade transitional celltumors, genitourinary tract .k 1685 to 2075 17 to 407   fully sequenced, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 391/407
(96 %)
6 diff
(98.6 %id)
R52918 placenta .k 1711 to 2075 370 to 1       370/375
(98 %)
12 diff
(96.8 %id)
FN070115 breast carcinoma .k 1776 to 1837 62 to 1     Submitted on the opposite strand 62/62
(100 %)
0 diff
(100 %id)
AW628138 2 pooled high-grade transitional celltumors, genitourinary tract .k 1787 to 2094 308 to 1   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 308/308
(100 %)
0 diff
(100 %id)
T81768 liver and spleen .k 1852 to 2075 220 to 1       220/220
(100 %)
12 diff
(94.6 %id)
FN122686 breast carcinoma .k 1866 to 1960 1 to 96       96/102
(94 %)
2 diff
(98.1 %id)
BQ707371 Spleen .l 1 to 859 3 to 868 E208* tiling clone,   868/946
(91 %)
18 diff
(98.1 %id)
BM808991 brain, hippocampus .l 30 to 894 1 to 866 E154D D157E E158D D159S S160G ...     866/1025
(84 %)
17 diff
(98.4 %id)
BQ930686 sciatic nerve .l 471 to 1177 1 to 705       705/705
(100 %)
14 diff
(98.1 %id)
AA284211 germinal center B cell .l 527 to 837 1 to 308       308/308
(100 %)
1 diff
(99.7 %id)
BE221866 Kidney .l 644 to 1160 517 to 1   tiling clone,   517/517
(100 %)
0 diff
(100 %id)
T85473 liver and spleen .l 716 to 1053 1 to 348       348/355
(98 %)
16 diff
(95.5 %id)
BU951744 Pancreas, Purified pancreatic islet .l 1013 to 1484 1 to 472   fully sequenced,   472/472
(100 %)
3 diff
(99.4 %id)
CB267364 adipose .l 1032 to 1550 1 to 519   tiling clone,   519/519
(100 %)
0 diff
(100 %id)
CD368849 Alveolar Macrophage, lung .l 1166 to 1813 667 to 19   AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 649/649
(100 %)
2 diff
(99.7 %id)
AK090844 amygdala .l 1265 to 4026 1 to 2763   tiling clone, available from FLJ,   2763/2763
(100 %)
2 diff
(100.0 %id)
DA149308 amygdala .l 1266 to 1835 2 to 571   capped   570/572
(99 %)
2 diff
(99.7 %id)
AA283902 germinal center B cell .l 1320 to 1813 495 to 1       495/495
(100 %)
1 diff
(99.8 %id)
AA703521 liver and spleen .l 1342 to 1813 472 to 1       472/472
(100 %)
0 diff
(100 %id)
AW244138 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .l 1431 to 1813 383 to 1       383/383
(100 %)
0 diff
(100 %id)
BU951474 Pancreas, Purified pancreatic islet .l 1457 to 1815 360 to 1   fully sequenced,   360/360
(100 %)
7 diff
(98.1 %id)
T85375 liver and spleen .l 1496 to 1830 344 to 2       343/344
(99 %)
0 diff
(100 %id)
DA179029 amygdala .l 1625 to 2195 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
AV654100 corresponding non cancerous liver tissue .l 1836 to 2244 1 to 409     Submitted on the opposite strand 409/409
(100 %)
0 diff
(100 %id)
CN293211 embryonic stem cells, DMSO-treated H9 cellline .l 2206 to 2448 1 to 243   tiling clone,   243/243
(100 %)
0 diff
(100 %id)
FN087720 breast carcinoma .l 2962 to 3066 106 to 1     Submitted on the opposite strand 106/111
(95 %)
6 diff
(94.6 %id)
AV714990   .l 3041 to 3647 1 to 607       607/607
(100 %)
1 diff
(99.9 %id)
BQ007667 Chondrosarcoma, Left Pelvis .l 3252 to 4044 789 to 1   tiling clone,   789/789
(100 %)
4 diff
(99.5 %id)
W05478 lung .l 3342 to 3706 1 to 362   fully sequenced,   362/362
(100 %)
2 diff
(99.5 %id)
BX110900 placenta .l 3428 to 4026 1 to 598   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 598/598
(100 %)
3 diff
(99.5 %id)
BI467194 Pancreas, Purified pancreatic islet .l 3481 to 4029 550 to 1       550/550
(100 %)
2 diff
(99.7 %id)
DB301631 amygdala .l 3489 to 4026 538 to 1       538/538
(100 %)
1 diff
(99.9 %id)
FN131453 breast carcinoma .l 3526 to 3638 114 to 1     Submitted on the opposite strand 114/114
(100 %)
2 diff
(98.3 %id)
AI610124 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .l 3594 to 4031 438 to 1       438/438
(100 %)
2 diff
(99.6 %id)
N71117 lung .l 3676 to 4026 349 to 1   fully sequenced,   349/349
(100 %)
3 diff
(99.2 %id)
R27066 placenta .l 3701 to 4027 329 to 1       329/329
(100 %)
25 diff
(92.5 %id)
DA398658 thalamus .l 3704 to 4261 2 to 558   tiling clone, capped   557/562
(99 %)
2 diff
(99.7 %id)
FN150563 breast carcinoma .l 3732 to 3863 130 to 1     Submitted on the opposite strand 130/130
(100 %)
3 diff
(97.7 %id)
TI_151728026   .m 1 to 659 747 to 90 F8X T40L Q41R A42Q T43P ... tiling clone, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 658/673
(97 %)
2 diff
(99.8 %id)
BG193438   .m 2 to 637 649 to 15 H2P F8L D9T R12* tiling clone, Submitted on the opposite strand 635/817
(77 %)
6 diff
(99.3 %id)
DB505836 hypothalamus .n 1 to 460 52 to 511   tiling clone,   460/511
(90 %)
6 diff
(98.9 %id)
BG715901 brain, hypothalamus .n 1 to 596 57 to 650 E2R L25W E26K E27N L28* tiling clone,   594/650
(91 %)
8 diff
(98.8 %id)
DB078725 testis .o 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DB082783 testis .o 13 to 564 2 to 554   tiling clone, capped   553/553
(100 %)
3 diff
(99.5 %id)
DB099107 testis .o 13 to 601 2 to 590 exact tiling clone, capped   589/589
(100 %)
1 diff
(99.9 %id)
BI050326 placenta_normal .p 1 to 453 464 to 13 G123D Y124M K126S Y127M E128N ... tiling clone,   452/464
(97 %)
0 diff
(100 %id)
BI461038 testis .q 1 to 617 1 to 617   tiling clone,   617/618
(99 %)
7 diff
(98.9 %id)
DB065736 testis .q 51 to 622 2 to 573   tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
BP213668 cerebrum .q 63 to 641 1 to 579 R53W tiling clone,   579/579
(100 %)
3 diff
(99.5 %id)
DB075804 testis .r 1 to 538 2 to 539 exact tiling clone, capped   538/538
(100 %)
0 diff
(100 %id)
BF030061 hypernephroma, Kidney .s 1 to 672 1 to 662 C62A P63L D64T L65C Q66S ... tiling clone,   662/873
(75 %)
24 diff
(97.3 %id)
AL703653 human skeletal muscle .t 1 to 609 1 to 612 S96X N97X D109X tiling clone,   612/612
(100 %)
6 diff
(99.1 %id)
BG619258 placenta .u 1 to 833 1 to 835   tiling clone,   835/835
(100 %)
18 diff
(97.9 %id)
BQ447124 Knee, Osteoarthritic Cartilage .u 348 to 1004 675 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 657/661
(99 %)
2 diff
(99.7 %id)
AA703213 liver and spleen .u 539 to 1010 472 to 1 exact     472/472
(100 %)
1 diff
(99.8 %id)
AI805881 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .u 583 to 1031 449 to 1 exact tiling clone,   449/449
(100 %)
0 diff
(100 %id)
BF223677 carcinoid, lung .u 605 to 1017 416 to 4 exact     413/416
(99 %)
0 diff
(100 %id)
AI348279 carcinoid, lung .u 620 to 1016 397 to 1 exact     397/397
(100 %)
0 diff
(100 %id)
AI873658 serous papillary carcinoma, high grade, 2pooled tumors, uterus .u 693 to 1015 323 to 1 exact     323/324
(99 %)
0 diff
(100 %id)
DB055776 testis .va-u 1 to 546 2 to 548   tiling clone, capped   547/547
(100 %)
1 diff
(99.9 %id)
AL832897 lymph node .va-u 358 to 4729 1 to 4372 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 4372/4372
(100 %)
7 diff
(99.9 %id)
BI027078 marrow .va-u 1174 to 1401 228 to 1       228/228
(100 %)
0 diff
(100 %id)
DA122554 cerebellum .va-u 1513 to 2047 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
BF512223   .va-u 1527 to 2084 575 to 18   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 558/574
(97 %)
0 diff
(100 %id)
DA308708 hippocampus .va-u 1936 to 2506 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BF843259 head_neck .va-u 2268 to 2742 483 to 10     Submitted on the opposite strand 474/483
(98 %)
8 diff
(98.4 %id)
DA944769 Spleen .va-u 2512 to 3066 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
AW277053 ovary, papillary serous ovarian metastasis .va-u 3466 to 3927 1 to 462     Submitted on the opposite strand 462/462
(100 %)
4 diff
(99.2 %id)
BF364321 nervous_normal .va-u 3507 to 3826 323 to 5       319/333
(95 %)
0 diff
(100 %id)
FN052247 breast carcinoma .va-u 3510 to 3612 1 to 103       103/103
(100 %)
1 diff
(99.1 %id)
CN290182 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .va-u 3531 to 4099 1 to 571   tiling clone,   571/572
(99 %)
3 diff
(99.5 %id)
CB153391 Liver .va-u 3548 to 4131 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
AW838609 leiomios .va-u 3578 to 4052 1 to 475       475/475
(100 %)
9 diff
(98.2 %id)
DB367466   .va-u 3732 to 4262 1 to 529     Submitted on the opposite strand 529/534
(99 %)
21 diff
(96.1 %id)
AI521612 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .va-u 3877 to 4376 1 to 500     Submitted on the opposite strand 500/500
(100 %)
6 diff
(98.8 %id)
AW900804 nervous_normal .va-u 3911 to 4293 13 to 396       384/396
(96 %)
6 diff
(98.5 %id)
BQ376456 testis_normal .va-u 3958 to 4307 23 to 373       351/373
(94 %)
6 diff
(98.4 %id)
BF360966 ovary .va-u 3996 to 4232 5 to 242       238/247
(96 %)
6 diff
(97.6 %id)
AW884932 ovary .va-u 3998 to 4232 4 to 239       236/243
(97 %)
7 diff
(97.2 %id)
TI_149289362   .va-u 4112 to 4745 717 to 88   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 630/631
(99 %)
7 diff
(98.9 %id)
BM970923 lung .va-u 4158 to 4745 605 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 587/587
(100 %)
3 diff
(99.5 %id)
N64664 multiple sclerosis lesions .va-u 4190 to 4729 571 to 21   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 551/551
(100 %)
14 diff
(97.5 %id)
DB308375 hippocampus .va-u 4222 to 4729 508 to 1       508/508
(100 %)
0 diff
(100 %id)
BQ008280 Chondrosarcoma, Left Pelvis .va-u 4256 to 4718 480 to 19   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 462/462
(100 %)
2 diff
(99.6 %id)
AI445832 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .va-u 4273 to 4745 473 to 1       473/474
(99 %)
3 diff
(99.4 %id)
AI690742 serous papillary carcinoma, high grade, 2pooled tumors, uterus .va-u 4273 to 4726 463 to 10       454/463
(98 %)
0 diff
(100 %id)
AI380619 B-cell, chronic lymphotic leukemia .va-u 4277 to 4729 469 to 17   AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 453/453
(100 %)
1 diff
(99.8 %id)
AI538903 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .va-u 4299 to 4746 448 to 1   tiling clone,   448/448
(100 %)
10 diff
(97.8 %id)
BE182555 head_neck .va-u 4558 to 4716 156 to 314       254/314
(80 %)
11 diff
(96.5 %id)
BE182566 head_neck .va-u 4558 to 4713 146 to 301       250/301
(83 %)
11 diff
(96.4 %id)
DA325487 hippocampus .vb-u 1 to 616 2 to 617   tiling clone, capped   616/616
(100 %)
0 diff
(100 %id)
AA161447   .vb-u 46 to 554 1 to 514       514/514
(100 %)
16 diff
(96.9 %id)
DB077382 testis .vb-u 97 to 616 2 to 522   capped   521/521
(100 %)
11 diff
(97.9 %id)
DB136576 thymus .vb-u 108 to 616 2 to 511   capped   510/510
(100 %)
1 diff
(99.9 %id)
DB143775 thymus .vb-u 364 to 924 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
BX495621 Liver .vb-u 380 to 866 12 to 500       489/500
(97 %)
6 diff
(98.8 %id)
CD655702 Embryonic Stem cells .vb-u 566 to 1333 11 to 774 L6P tiling clone,   764/844
(90 %)
16 diff
(98.2 %id)
DB315772 brain .vb-u 707 to 1241 1 to 535 exact   Submitted on the opposite strand 535/535
(100 %)
0 diff
(100 %id)
BG997254 head_neck .vb-u 757 to 1071 317 to 5       313/320
(97 %)
0 diff
(100 %id)
BI028396 marrow .vb-u 870 to 1078 237 to 18       220/244
(90 %)
0 diff
(100 %id)
BM919104 pooled pancreas and spleen .vb-u 875 to 1773 12 to 909 exact tiling clone,   898/1063
(84 %)
15 diff
(98.6 %id)
DB118963 thymus .vb-u 883 to 1437 2 to 559 L19P K21E L22I W23V L24A ... capped   558/558
(100 %)
4 diff
(99.3 %id)
BF899662 marrow .vb-u 980 to 1448 469 to 1 L51F   Submitted on the opposite strand 469/470
(99 %)
3 diff
(99.4 %id)
DA110258 cerebellum .vb-u 1129 to 1675 2 to 548   tiling clone, capped   547/547
(100 %)
0 diff
(100 %id)
AA383393 testis .vb-u 1145 to 1353 1 to 209       209/209
(100 %)
0 diff
(100 %id)
BF355089 head_neck .vb-u 1399 to 1645 4 to 251       248/251
(98 %)
6 diff
(97.7 %id)
DB089415 testis .vc 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
AL704901 human skeletal muscle .vc 427 to 1009 1 to 582 exact tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
BX106220 liver and spleen .vd-u 1 to 748 1 to 748 exact tiling clone,   748/748
(100 %)
0 diff
(100 %id)
H59493 liver and spleen .vd-u 20 to 392 1 to 380 A7X V21X E31G G32X L33A ...     380/381
(99 %)
12 diff
(96.9 %id)
AI684731 pooled .vd-u 83 to 599 1 to 517 exact   Submitted on the opposite strand 517/517
(100 %)
4 diff
(99.3 %id)
AI685321 pooled .vd-u 86 to 494 1 to 408 exact   Submitted on the opposite strand 408/408
(100 %)
3 diff
(99.3 %id)
AI219452 pooled .vd-u 87 to 512 1 to 426 exact   Submitted on the opposite strand 426/426
(100 %)
2 diff
(99.6 %id)
AI658929 Prostate .vd-u 456 to 796 370 to 30   tiling clone, AAA Possibly primed on the genome, locally A rich (28/29 A in genome downstream of last aligned base) 341/341
(100 %)
1 diff
(99.8 %id)
AW300255 Kidney .vd-u 494 to 797 308 to 5   tiling clone,   304/308
(98 %)
0 diff
(100 %id)
AW845281 colon .ve-u 1 to 211 4 to 214   tiling clone,   211/214
(98 %)
2 diff
(99.1 %id)
BX496213 Liver .ve-u 121 to 635 1 to 515 R10W tiling clone,   515/515
(100 %)
3 diff
(99.5 %id)
DB267851 uterus .vf 1 to 573 2 to 574 exact tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
AL596977   .vg-u 1 to 573 1 to 574 exact tiling clone,   574/576
(99 %)
6 diff
(99.0 %id)
DB020788 testis .vh 1 to 552 2 to 550 E2G E22D D25E E26D D27S ... tiling clone, capped   549/552
(99 %)
8 diff
(98.6 %id)
DB055926 testis .vi 1 to 544 2 to 545 exact tiling clone, capped   544/544
(100 %)
1 diff
(99.9 %id)
BG195452   Gene NRD1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
522 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb-u, .vc, .vd-u, .ve-u, .vf, .vg-u, .vh, .vi Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI